Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Plerixafor

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 242,851Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Gland Pharma's Generic Plerixafor Receives Approval in the U.S
    Gland Pharma's Generic Plerixafor Receives Approval in the U.S

    03 May 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206644

    FDA
    03 May 2024
    Share Share
    Fresenius Kabi Launches Plerixafor Injection
    Fresenius Kabi Launches Plerixafor Injection

    09 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230809432476/en

    BUSINESSWIRE
    09 Aug 2023
    Share Share
    Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. About the subsidiary product Plerixafor Injection Announcement of US FDA approval
    Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. About the subsidiary product Plerixafor Injection Announcement of US FDA approval

    26 Jul 2023

    // PRESS RELEASE

    https://www.pharmacompass.com/pdf/news/nanjing-jianyou-biochemical-pharmaceutical-co-ltd-about-the-subsidiary-product-plerixafor-injection-announcement-of-us-fda-approval-54126.pdf

    PRESS RELEASE
    26 Jul 2023
    Share Share
    Aurobindo Pharma arm gets USFDA nod for Plerixafor injection
    Aurobindo Pharma arm gets USFDA nod for Plerixafor injection

    25 Jul 2023

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-pharma-arm-gets-usfda-nod-for-plerixafor-injection/articleshow/102102608.cms

    ECONOMIC TIMES
    25 Jul 2023
    Share Share
    Zydus' Generic Plerixafor Receives Receives Approval in the U.S.
    Zydus' Generic Plerixafor Receives Receives Approval in the U.S.

    11 May 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208980

    FDA
    11 May 2023
    Share Share
    Accord Healthcare's Plerixafor Approved In Europe
    Accord Healthcare's Plerixafor Approved In Europe

    06 Feb 2023

    // EMA

    https://www.ema.europa.eu/en/documents/overview/plerixafor-accord-epar-medicine-overview_en.pdf

    EMA
    06 Feb 2023
    Share Share